Evidence map›Paper›PMID 39984524›Full record

Articlenpj aging2025

Calcium (Ca

Andrea Puebla-Huerta, Hernán Huerta, Camila Quezada-Gutierez, Pablo Morgado-Cáceres, César Casanova-Canelo, Sandra A Niño, Sergio Linsambarth, Osman Díaz-Rivera, José Alberto López-Domínguez, Sandra Rodríguez-López and 15 more

Abstract read
In one paragraph

Article in npj aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Andrea Puebla-Huerta *Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
Hernán Huerta *Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
Camila Quezada-GutierezCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
Pablo Morgado-CáceresCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
César Casanova-CaneloCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
Sandra A NiñoGeroscience Center for Brain Health and Metabolism, Santiago, Chile.ORCID http://orcid.org/0000-0001-7665-2468
Sergio LinsambarthCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
Osman Díaz-RiveraCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.ORCID http://orcid.org/0009-0008-0906-1308
José Alberto López-DomínguezInstituto de Biología Molecular y Celular del Cáncer and Centro de Investigación del Cáncer of Salamanca, University of Salamanca-CSIC, Salamanca, Spain.
Sandra Rodríguez-LópezDepartamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, Campus de Excelencia Internacional Agroalimentario, CeiA3, Córdoba, Spain.ORCID http://orcid.org/0000-0002-5088-6458
José Antonio González-ReyesDepartamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, Campus de Excelencia Internacional Agroalimentario, CeiA3, Córdoba, Spain.ORCID http://orcid.org/0000-0003-1918-5490
Galdo BustosCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.ORCID http://orcid.org/0000-0002-4430-4271
Eduardo Silva-PavezCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
Alenka LovyCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
Gabriel QuirozGeroscience Center for Brain Health and Metabolism, Santiago, Chile.
Catalina González-SeguelCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
Edison Salas-HuenuleoAdvanced Integrated Technologies (AINTECH), Santiago, Chile.
Marcelo J KoganDepartamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santos Dumont, Santiago, Chile.
Jordi MolgóUniversité Paris-Saclay, CEA, Département Médicaments et Technologies pour la Santé, Service d'Ingénierie Moléculaire pour la Santé (SIMoS), Equipe Mixte de Recherche CNRS 9004, Gif-sur-Yvette, France.
Armen ZakarianDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, CA, USA.
José M VillalbaDepartamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, Campus de Excelencia Internacional Agroalimentario, CeiA3, Córdoba, Spain.ORCID http://orcid.org/0000-0001-8554-3802
Christian Gonzalez-BillaultGeroscience Center for Brain Health and Metabolism, Santiago, Chile.ORCID http://orcid.org/0000-0003-0335-1482
Tito CalìDepartment of Biomedical Sciences, University of Padua, Padua, Italy; Centro Studi per la Neurodegenerazione (CESNE), University of Padua, Padua, Italy; Neuroscience Center (PNC), University of Padua, Padua, Italy.
Ulises Ahumada-CastroCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile. ulises.ahumada@uss.cl.
J César CárdenasCenter for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile. julio.cardenas@umayor.cl.ORCID http://orcid.org/0000-0003-1115-2790

Funding

Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) RO1 077379Fondo Nacional de Desarrollo Científico y Tecnológico (National Fund for Scientific and Technological Development) 3220593Fondo Nacional de Desarrollo Científico y Tecnológico (National Fund for Scientific and Technological Development) 3220604Fondo Nacional de Desarrollo Científico y Tecnológico (National Fund for Scientific and Technological Development) 3230273Fondo Nacional de Desarrollo Científico y Tecnológico (National Fund for Scientific and Technological Development) 3230476
6 · The paper itself

Abstract

Therapy-induced senescence (TIS) alters calcium (Ca²⁺) flux and Mitochondria-ER Contact Sites (MERCS), revealing critical vulnerabilities in senescent cells. In this study, TIS was induced using Doxorubicin and Etoposide, resulting in an increased MERCS contact surface but a significant reduction in ER-mitochondria Ca²⁺ flux. Mechanistically, TIS cells exhibit decreased expression of IP3R isoforms and reduced interaction between type 1 IP3R and VDAC1, impairing Ca²⁺ transfer. This flux is crucial for maintaining the viability of senescent cells, highlighting its potential as a therapeutic target. Inhibition of ER-mitochondria Ca²⁺ flux demonstrates senolytic effects both in vitro and in vivo, offering a novel strategy for targeting senescent cells.

Identifiers

PMID39984524
PMCPMC11845618

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.